Since it has been demonstrated that recent and remote TBI subjects, naïve for TB therapy, had a similar CD4 cytokine profile (29), the functional differences after TB therapy between TBI and TBI-IMID individuals were not ascribable to their remote or recent Mtb exposure but probably to the IMID status itself. This evidence concerns the gene CD4 and tuberculosis.